PPARGC1A and neoplasm: The PI3K/Akt/mTOR signalling axis also increases lipid metabolism in tumours by the production of lipogenic enzymes via SREBP activity183 and decreases antitumor immunity by reducing PGC1α expression in tumour-infiltrating lymphocytes, resulting in their exhaustion.184